92 / 210
S84
Poster presentations / European Geriatric Medicine 6S1 (2015) S32
–
S156
Conclusion:
A dementia village is a novel concept, that would result
in a more active, comprehensive and humane way for dementia
patients to live, without being handicapped by their condition.
Frailty and sarcopenia
P-197
Development and validation of a self-administrated quality
of life questionnaire specific to sarcopenia: the SarQoL
C. Beaudart
1
, J.-Y. Reginster
2
, R. Rizzoli
3
, E. Biver
3
, Y. Rolland
4
,
I. Bautmans
5
, J. Petermans
2
, S. Gillain
6
, F. Buckinx
2
, J. Van Beveren
2
,
M. Jacquemain
2
, P. Italiano
2
, N. Dardenne
2
, O. Bruy `ere
2
1
University of Li`ege, Liege, Belgium;
2
University of Li`ege, Li`ege,
Belgium;
3
Geneva University Hospitals and Faculty of Medicine,
Geneva, Switzerland;
4
G´erontologie clinique et m´edecine interne,
Toulouse;
5
Belgium;
6
Chu Liege, Chenee, Belgium
Objectives:
The aim of this study was to develop and validate
a sarcopenia-specific quality of life questionnaire (SarQoL,
Sarcopenia & Quality of Life questionnaire).
Methods:
The development part of the questionnaire was
articulated in four stages: 1. Item generation; 2. Item reduction;
3. Questionnaire generation; 4. Pre-test of the questionnaire. To
validate the SarQoL, we assessed its discriminative power (logistic
regression), internal consistency (Cronbach’s alpha), construct
validity (Spearman Correlation), test-retest reliability (ICC) and floor
and ceiling effects.
Results:
The final version of the questionnaire consists of 55 items
divided into 7 domains, translated into 22 questions to be rated
on a 4-point Likert scale. The pre-test indicates that the SarQoL
is easy to complete independently, in approximately 10 minutes.
The SarQoL significantly discriminated sarcopenic subjects from
non-sarcopenic ones (p
<
0.001). Internal consistency was good
with a Cronbach’s alpha= 0.87. The SarQoL had a good convergent
validity with, for example, the domain of functional score (r = 0.52,
p
<
0.001) and vitality (r = 0.72, p
<
0.001) of the SF-36 questionnaire.
Divergent validity has been found with, for example, the EQ-5D
pain (r = −0.12). Test-retest reliability was good with an ICC of 0.91
(0.82–0.95). Neither floor nor ceiling effects has been found.
Conclusions:
The first version of the SarQoL, a quality of life
questionnaire specific for sarcopenic subjects, has been developed
and has been shown to be understandable by the target population.
This French version of the SarQoL is valid, consistent and reliable
and can therefore be recommended for clinical and research
purposes, and for translation in various languages.
P-198
Systematic screening of sarcopenia in geriatric day hospital
N. Berg
1
, C. Gazzotti
1
1
CHR Citadelle, Li`ege, Belgium
Objectives:
1. Verify the feasibility to implement a simple tool of sarcopenia’s
screening by patients admitted in the geriatric day hospital.
2. Measure the prevalence of sarcopenia for those patients.
3. Look for possible correlations with the origin of the patient, his
sex, the amount of taken medicine and his autonomy.
Methods:
The patients aged 75 years or more are considered. A
collection of geriatric basic data is realised for all the patients (new
or not seen for one year). The sarcopenia’s evaluation follows the
EWGSOP’s consensus.
Results:
During the period between 02.17.2014 and 02.09.2015, 428
patients benefited from a sarcopenia screening and the collection
of geriatric data. Incidence of sarcopenia: 31.2% incidence.
Sarcopenic patients have a mean age of 84.15 years, are
institutionalized in 27.6% of the cases, a Katz’s scale average of
10.32/24 and an average number of medicine taken in 8.80.
Respectively for non-sarcopenic patients the data are: 82.74
years (statistically significant difference SS), 26.7% institutionalized
(statistically non-significant difference NS), Katz’s of 9.28 (SS) and
8.34 medicine taken (NS).
42.1% of sarcopenic patients are men and 23.9% of non
sarcopenic (SS).
Conclusions:
The systematic screening of sarcopenia is possible at
a practical level as part of the patient care in the geriatric day
hospital. The prevalence of sarcopenia measured according to this
flowchart is 31.2%. Sarcop ´enia is more often found in men, older
people and at the more dependent patients for the ADL.
P-199
Frailty and Sarcopenia in Colombia: Results from the SABE
Bogot´a Study
C.A. Cano
1
, R. Sampert-Ternet
1
, M.G. Borda
1
, A.J. Arciniegas
1
1
Pontificia Universidad Javeriana
–
Hospital San Ignacio, Bogot´a,
Colombia
Objective:
Analyze the coexistence of frailty and sarcopenia in a
sample of community-dwelling older adults and identify variables
that increase or decrease the odds of developing these conditions.
Methods:
Data comes from the SABE Bogot ´a Study, a cross-sectional
study conducted in the capital of Colombia in 2012. A total
of 2000 adults aged 60 years and older were interviewed and
sociodemographic, health, cognitive and anthropometric measures
were collected. The frailty phenotype the European Sarcopenia
Working Group algorithm were used to define both conditions.
Logistic regression analyses were used to identify factors associated
with increased or decreased odds of developing frailty and
sarcopenia.
Results:
A total of 135 older adults have frailty (9.4%) and 166
sarcopenia (11.5%). Older age and female gender significantly
increased the odds of both frailty and sarcopenia (Frailty: Age OR
1.05, 95% CI 1.03–1.06, Gender OR 1.44, 95% CI 1.12–1.84; Sarcopenia:
Age 1.04, 95% CI 1.02–1.07, Gender OR 1.51, 95% CI 1.05–2.17).
Depression significantly increased the odds of frailty (OR 1.17, 95% CI
1.12–1.22) and smoking the odds of sarcopenia (OR 2.38, 95% CI
1.29–4.37). Conversely, higher function significantly decreased the
odds of frailty (OR 0.74, 95% CI 0.64–0.86).
Conclusions:
There are potentially reversible factors that increase
the odds of frailty and sarcopenia among older adults in
Colombia. Frailty, sarcopenia and multimorbidity are overlapping,
yet distinct conditions in our sample. Future studies need to
identify interventions to prevent these conditions, and examine
individuals that have frailty, sarcopenia and comorbidities to design
interventions to improve their quality-of-life.
P-200
Correlation between muscle mass and muscle strength among
nursing home residents
F. Buckinx
1
, J.-L. Croisier
1
, J.-Y. Reginster
1
, J. Petermans
1
,
O. Bruy `ere
1
1
University of Li`ege, Li`ege, Belgium
Background:
This study aimed to assess the correlation between
muscle mass and muscle strength among nursing home residents.
Methods:
One-hundred nursing home residents (85% of women)
aged 80.1
±
10.1 years were included in this cross-sectional study
performed in Li `ege, Belgium. Muscle mass, specifically appendicular
lean mass divided by the square of the height (ALM/ht
2
), was
assessed using a bioelectrical impedance analyzer (InBody S10).
Muscle strength was measured with a hydraulic dynamometer
(hand grip strength) and with a hand-held dynamometer (knee
extensors, knee flexors, ankle extensors, ankle flexors, hip